These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy. Aiuti F, Rossi P, Sirianni MC, Carbonari M, Popovic M, Sarngadharan MG, Contu L, Moroni M, Romagnani S, Gallo RC. Br Med J (Clin Res Ed); 1985 Jul 20; 291(6489):165-6. PubMed ID: 2990634 [Abstract] [Full Text] [Related]
4. Demonstration of antibodies to human T-lymphotropic retrovirus type III in lymphoadenopathy syndrome patients and in individuals at risk for acquired immune deficiency syndrome (AIDS) in Italy. Sirianni MC, Rossi P, Moroni M, Romagnani S, Lazzarin A, Carbonari M, Scarpati B, Mariani M, Manconi PE, Del Giacco GS. Am J Epidemiol; 1986 Feb 20; 123(2):308-15. PubMed ID: 3004198 [Abstract] [Full Text] [Related]
6. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Safai B, Sarngadharan MG, Groopman JE, Arnett K, Popovic M, Sliski A, Schüpbach J, Gallo RC. Lancet; 1984 Jun 30; 1(8392):1438-40. PubMed ID: 6145881 [Abstract] [Full Text] [Related]
7. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Cheingsong-Popov R, Weiss RA, Dalgleish A, Tedder RS, Shanson DC, Jeffries DJ, Ferns RB, Briggs EM, Weller IV, Mitton S. Lancet; 1984 Sep 01; 2(8401):477-80. PubMed ID: 6147546 [Abstract] [Full Text] [Related]
8. Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III. Abb J. Med Microbiol Immunol; 1985 Sep 01; 174(4):205-10. PubMed ID: 2999573 [Abstract] [Full Text] [Related]
9. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany. Hehlmann R, Kreeb G, Erfle V, Piechowiak H, Krüger G, Goebel FD. Blut; 1985 Jan 01; 50(1):13-8. PubMed ID: 2981593 [Abstract] [Full Text] [Related]
10. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. Sundqvist VA, Linde A, Kurth R, Werner A, Helm EB, Popovic M, Gallo RC, Wahren B. J Infect Dis; 1986 May 01; 153(5):970-3. PubMed ID: 3009638 [No Abstract] [Full Text] [Related]
11. Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission. Kreiss JK, Kitchen LW, Prince HE, Kasper CK, Essex M. Ann Intern Med; 1985 May 01; 102(5):623-6. PubMed ID: 2984972 [Abstract] [Full Text] [Related]
12. Impairment of cellular immunity and OKT4 lymphocytes in symptom-free hemophiliacs with antibodies to human T leukemia virus III (HTLV III). Pandolfi F, De Rossi G, Mariani G, Carbonari M, Ensoli B, Napolitano M, Lopez M, Mandelli F, Aiuti F. Diagn Immunol; 1985 May 01; 3(3):155-9. PubMed ID: 2996821 [Abstract] [Full Text] [Related]
16. Antiviral antibodies in the sera of homosexual men: correlation with their lifestyle and drug usage. Nerurkar LS, Biggar RJ, Goedert JJ, Wallen W, Becker P, West F, Tzan N, Traub R, Lee YJ, Botelar W. J Med Virol; 1987 Feb 01; 21(2):123-35. PubMed ID: 3029318 [Abstract] [Full Text] [Related]
17. The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy. Boyko WJ, Schechter MT, Jeffries E, Douglas B, Maynard M, O'Shaughnessy M. Can Med Assoc J; 1985 Jul 01; 133(1):28-32. PubMed ID: 2988730 [Abstract] [Full Text] [Related]